Detalhe da pesquisa
1.
Sorafenib with or without concurrent transarterial chemoembolization in patients with advanced hepatocellular carcinoma: The phase III STAH trial.
J Hepatol
; 70(4): 684-691, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30529387
2.
Real-life effectiveness and safety of the daclatasvir/asunaprevir combination therapy for genotype 1b chronic hepatitis C patients: An emphasis on the pretreatment NS5A resistance-associated substitution test.
J Med Virol
; 91(12): 2158-2165, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31452206
3.
Chronic Hepatitis B Infection Is Significantly Associated with Chronic Kidney Disease: a Population-based, Matched Case-control Study.
J Korean Med Sci
; 33(42): e264, 2018 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30310365
4.
Daclatasvir/asunaprevir/beclabuvir, all-oral, fixed-dose combination for patients with chronic hepatitis C virus genotype 1.
J Gastroenterol Hepatol
; 32(12): 1998-2005, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28370350
5.
Treatment rate and factors related to interferon-based treatment initiation for chronic hepatitis C in South Korea.
J Med Virol
; 88(2): 275-81, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26211752
6.
All-oral daclatasvir plus asunaprevir for chronic hepatitis C virus (HCV) genotype 1b infection: a sub-analysis in Asian patients from the HALLMARK DUAL study.
Liver Int
; 36(10): 1433-41, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27009831
7.
Daclatasvir plus asunaprevir for HCV genotype 1b infection in patients with or without compensated cirrhosis: a pooled analysis.
Liver Int
; 36(7): 954-62, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26683763
8.
Tenofovir monotherapy versus tenofovir plus lamivudine or telbivudine combination therapy in treatment of lamivudine-resistant chronic hepatitis B.
Antimicrob Agents Chemother
; 59(2): 972-8, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25421484
9.
All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study.
Lancet
; 384(9954): 1597-605, 2014 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25078304
10.
Accuracy of transient elastography in assessing liver fibrosis in chronic viral hepatitis: A multicentre, retrospective study.
Liver Int
; 35(10): 2246-55, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25682719
11.
Prospective cohort study on the outcomes of hepatitis C virus-related cirrhosis in South Korea.
J Gastroenterol Hepatol
; 30(8): 1281-7, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25778783
12.
High-dose proton pump inhibitor treatment is associated with a higher mortality in cirrhotic patients: A multicentre study.
Aliment Pharmacol Ther
; 59(8): 973-983, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38389319
13.
Clinical and epidemiological features of hepatitis C virus infection in South Korea: a prospective, multicenter cohort study.
J Med Virol
; 85(10): 1724-33, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23813472
14.
A nationwide seroepidemiology of hepatitis C virus infection in South Korea.
Liver Int
; 33(4): 586-94, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23356674
15.
Clinical features of autoimmune hepatitis and comparison of two diagnostic criteria in Korea: a nationwide, multicenter study.
J Gastroenterol Hepatol
; 28(1): 128-34, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23033899
16.
Prevalence, incidence, and outcomes of hepatitis E virus coinfection in patients with chronic hepatitis C.
Sci Rep
; 13(1): 13632, 2023 08 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37604848
17.
Next-generation sequencing analysis of hepatitis C virus resistance-associated substitutions in direct-acting antiviral failure in South Korea.
Clin Mol Hepatol
; 29(2): 496-509, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36880209
18.
Etiology and clinical characteristics of acute viral hepatitis in South Korea during 2020-2021: a prospective multicenter study.
Sci Rep
; 13(1): 14271, 2023 08 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37652984
19.
Efficacy and safety of sofosbuvir-velpatasvir and sofosbuvir-velpatasvir-voxilaprevir for hepatitis C in Korea: a Phase 3b study.
Korean J Intern Med
; 38(4): 504-513, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37424500
20.
Efficacy of thymosin α-1 plus peginterferon α-2a combination therapy compared with peginterferon α-2a monotherapy in HBeAg-positive chronic hepatitis B: a prospective, multicenter, randomized, open-label study.
Scand J Gastroenterol
; 47(8-9): 1048-55, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22726105